Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Quarterly report · Q2

4594.TEDINET S100S6UQ
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥44,0002023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥179,0002022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥551m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income−¥805m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥552m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥810m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥553m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥810m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥554m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥811m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥1.2bnat 2023-09-30StandaloneAssets
Total assets¥1.7bnat 2023-03-31StandaloneAssets
Total assets¥2.1bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥150mat 2023-09-30StandaloneLiabilities
Total liabilities¥134mat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.0bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.0bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.5bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥466m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥589m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥1m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥432m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥197m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-8.812023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.12023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.22022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.522022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio85.4%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.8%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued62,891,200at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued58,903,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 342
ItemContextValueUnit
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember-64000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YTDDuration_NonConsolidatedMember805000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYTDDuration_NonConsolidatedMember660000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember198200000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember86468000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-585995000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-464436000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember13000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember9000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-202000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-2420000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-1900000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-588604000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-466327000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember-1454000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-1454000JPY
Redemption of bonds fin cfPrior1YTDDuration_NonConsolidatedMember-87500000JPY
Redemption of bonds fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Purchase of treasury stock fin cfPrior1YTDDuration_NonConsolidatedMember-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember284991000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember197491000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember－JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-391113000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-467781000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember2305026000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1530969000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember1913913000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember1063188000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember643726000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember363891000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember407000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember－JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第21期第２四半期(自 2023年７月１日 至 2023年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)ブライトパス・バイオ株式会社
Company name in english cover pageFilingDateInstantBrightPath Biotherapeutics Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　永井 健一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)神奈川県川崎市川崎区殿町三丁目25番22号
Telephone number address of registered headquarter cover pageFilingDateInstant044-440-3939
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役CFO　竹下 陽一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区麹町二丁目２番地４
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5840-7697(代表)

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass